Cardiac Risk Assessment — Miami

Cardiac Risk Assessment in Miami — Cleerly AI Coronary Imaging, Genetic and Extensive Biomarker Testing

Heart disease kills one American every 33 seconds (according to the Centers for Disease Control and Prevention), and for many people the first symptom is a heart attack. The diagnostic tools most physicians rely on are built to detect disease that has already progressed, not disease in its earliest, most treatable stages.

Nivaan Health takes a different approach. Through Cleerly AI coronary imaging and continuous cardiovascular monitoring, our physicians identify plaque buildup and measure cardiac risk years before a traditional screening would raise a flag.

Your Heart Deserves More Than a Cholesterol Check

Most cardiac risk goes undetected until it becomes a crisis. A cardiac risk assessment with Cleerly AI coronary imaging gives your physician a complete picture of your coronary health, at the stage when intervention still prevents damage.

Schedule a Discovery Call (786) 475-2812

Nivaan Health — cardiac risk assessment and Cleerly AI coronary imaging in Miami

The Screening Gap

Why Traditional Cardiac Screening Misses the Disease That Kills

Most annual physicals include a cholesterol check and possibly an EKG. If symptoms appear, a stress test follows. These tools have genuine clinical value, but they share a significant limitation: they measure downstream effects rather than the disease itself.

01

The Standard Tests

The Problem with Stress Tests and Lipid Panels

A standard lipid panel measures circulating cholesterol, which accounts for roughly 50% of cardiovascular events. Half of all heart attacks occur in people with cholesterol levels considered normal by conventional benchmarks, a finding documented in research published in the Journal of the American College of Cardiology. An EKG records electrical activity in the heart, not the condition of the coronary arteries supplying blood to the heart muscle.

The Blind Spot

What a Stress Test Cannot Show

Stress tests detect blockages already severe enough to restrict blood flow during exercise, typically narrowing of 70% or greater. A patient can carry a 50% blockage composed of unstable, lipid-rich, rupture-prone plaque and return with a clean result.

02

The Silent Progression

What Coronary Artery Disease Looks Like Before Symptoms Appear

Coronary artery disease develops gradually through the accumulation of atherosclerotic plaque in the arterial wall. In its early stages, the artery wall expands outward to accommodate the buildup, a process called positive remodeling, which preserves the inner opening of the vessel and masks disease severity on conventional imaging.

The Danger Markers

The Plaque Features That Matter Most

Plaques most likely to rupture and cause acute coronary events are often not the largest ones. They carry three specific structural characteristics:

A lipid-rich core with low attenuation on imaging
Spotty calcification within soft, unstable plaque
Positive arterial remodeling that conceals true disease burden

Detecting these features requires coronary imaging technology designed specifically to find them.

The Full Picture

Find Out What Your Current Cardiac Screening May Be Missing

If your last physical included a cholesterol panel and a stress test, you have a partial picture of your cardiovascular health. A cardiac risk assessment built around advanced coronary imaging gives you the full one.

Schedule a Discovery Call

Cleerly AI Coronary Imaging

Coronary Plaque Analysis — Seeing What Standard Imaging Misses

Coronary CT angiography creates detailed, three-dimensional images of the coronary arteries in approximately 10 to 15 minutes with no recovery requirement. Your Nivaan physician orders the scan and interprets the results through Cleerly, an FDA-cleared AI platform that analyzes CTA data to quantify and categorize plaque composition, not just measure the degree of blockage.

Standard imaging describes a blockage as a percentage of narrowing. Cleerly AI coronary imaging gives your physician a vessel-by-vessel breakdown of total plaque burden, plaque type (calcified, fibrous, or low-attenuation) and stenosis severity measured in both 2D and 3D. That distinction matters because the plaques most likely to rupture are often not the largest ones. They are soft, lipid-rich, and invisible to conventional screening.

The scan produces the map. Your Nivaan physician builds the plan. Plaque composition and burden data inform whether the appropriate response is aggressive lipid-lowering therapy, metabolic intervention, lifestyle modification, specialist referral, or a combination. Decisions that a standard lipid panel cannot support with the same precision.

For patients building a proactive cardiovascular record, coronary CTA with Cleerly analysis sets a quantitative starting point. Future scans measure disease progression or regression against that baseline, giving your physician objective evidence of whether treatment, medication, or lifestyle changes are working.

Coronary CTA with Cleerly analysis is available through Nivaan Health as a component of your executive health evaluation or Nirvana membership. Speak with a physician about whether this assessment is the appropriate next step for your cardiovascular health.

Book Your Cardiac Risk Assessment

Continuous Monitoring

Continuous Cardiac Monitoring — Closing the Gap Between Scans

A Cleerly scan answers one question: what is the current state of my coronary arteries? Biomarker and monitoring data answer a different one: why is disease developing, and how aggressively should we intervene? Both are necessary for a complete cardiovascular picture.

Inflammatory Biomarkers and Advanced Lipid Analysis

Nivaan physicians order a cardiac biomarker panel that goes well beyond the standard lipid screen. Each marker addresses a specific mechanism driving coronary artery disease that a cholesterol check alone cannot capture.

The Biomarkers Nivaan Physicians Assess

01

Apolipoprotein B

ApoB

A direct count of atherogenic lipoprotein particles. Research in JAMA Cardiology confirms ApoB outperforms LDL cholesterol as a predictor of cardiovascular events.

02

Lipoprotein(a)

Lp(a)

A genetically determined inflammatory particle that dramatically elevates heart attack and stroke risk and does not respond to lifestyle modification alone.

03

High-Sensitivity CRP and Inflammatory Markers

hs-CRP

Reveal systemic vascular inflammation even when cholesterol levels appear within normal range.

04

Insulin

Insulin Resistance

Assess insulin resistance, which drives accelerated atherosclerosis years before a diabetes diagnosis appears on a standard panel.

05

Homocysteine

Endothelial Marker

Indicates endothelial damage correctable with targeted B-vitamin supplementation when identified early.

Within Your Membership

Integrating Cardiac Monitoring into Your Nivaan Membership

Cardiac risk assessment is a structured component of the Nirvana membership annual health evaluation. Your physician coordinates the coronary CTA, reviews your Cleerly analysis, orders and interprets the advanced biomarker panel, and builds a personalized cardiovascular prevention strategy based on your results.

Intervals Set by Your Data

Monitoring Intervals Determined by Your Results

Follow-up intervals for repeat coronary imaging are set by baseline findings. A clean scan in a low-risk patient may warrant reassessment in three to five years. Identified plaque or high-risk plaque features may call for annual monitoring. Specialist referrals, medication management, and lifestyle protocol adjustments are coordinated directly by your Nivaan physician.

Physician-Led Oversight

Advanced Cardiovascular Prevention, Coordinated by Your Personal Physician

Continuous cardiac monitoring at this level of depth and longitudinal oversight is not available in a traditional primary care model. It requires the time, access, and clinical commitment that the Nirvana membership is built to provide.

Learn About the Nirvana Membership

The Right Time

Who Should Consider a Cardiac Risk Assessment

Proactive cardiac screening is most valuable for individuals who carry meaningful cardiovascular risk but have not yet developed symptoms. The relevant question is not whether you feel healthy today, but whether your current screening gives your physician enough information to detect disease at the stage when intervention is most effective.

Risk Factors

Risk Factors That Warrant Earlier Coronary Screening

Consider a heart disease risk assessment with coronary CTA if any of the following apply:

Family history of heart attack or coronary artery disease in a first-degree relative
Elevated Lp(a) on blood work
Prediabetes, insulin resistance, or metabolic syndrome
A calcium score that showed any calcified plaque
A prior stress test with inconclusive or borderline results
Multiple conventional cardiovascular risk factors in combination

Baseline Screening Age

When to Consider Your First Scan

40+

Men Should consider baseline coronary imaging starting around age 40.

50+

Women Should consider baseline screening around age 50 — or earlier if risk factors are present. Women carry a historically underdiagnosed cardiovascular risk burden.

Heart disease remains the number one cause of death in women according to the American Heart Association, a reality that standard screening protocols have not always reflected.

Not Sure?

Not Sure Whether Advanced Coronary Imaging Is Right for You?

A Nivaan physician will review your cardiovascular risk profile and help you determine whether a cardiac risk assessment in Miami with Cleerly AI imaging is the appropriate next step.

Talk to a Nivaan Physician

Prevention Over Crisis

The Case for Cardiac Risk Assessment as Preventive Medicine

Heart disease is largely preventable when identified at the right stage. Technology capable of detecting coronary artery disease years before a stress test would raise a concern exists today. Nivaan Health integrates Cleerly AI coronary imaging, advanced biomarker analysis, and continuous physician oversight into a single, coordinated cardiovascular prevention strategy available to every Nirvana member.

Advanced Cardiac Risk Assessment, Included in Your Nirvana Membership

Detecting plaque buildup early, understanding its composition, and monitoring the markers driving its development gives you and your physician the information needed to intervene before disease becomes a crisis. This is what proactive cardiac screening looks like when every layer is covered.

Schedule Your Cardiac Risk Assessment in Miami

Common Questions

Frequently Asked Questions About Cardiac Risk Assessment in Miami

A standard coronary calcium score confirms whether calcified plaque is present, but does not characterize its composition or identify soft, non-calcified plaque most likely to rupture. Coronary CTA with Cleerly AI analysis quantifies total plaque burden by type and location, measures stenosis severity in 2D and 3D, and assesses ischemic risk vessel by vessel. A calcium score of zero does not rule out soft plaque. Cleerly identifies what a calcium score cannot.

Cleerly coronary CTA is typically not covered by standard insurance plans when ordered as a preventive screening rather than for a symptomatic indication. Nivaan Health does not accept insurance. Membership fees cover physician coordination, interpretation, and the monitoring framework built around your results.

Repeat imaging intervals depend on baseline findings and cardiovascular risk profile. Patients with no identified plaque and low overall risk generally repeat coronary imaging every three to five years. Patients with identified plaque, elevated inflammatory markers, or high-risk plaque features may benefit from annual reassessment to track disease progression or regression in response to treatment. Your Nivaan physician determines your monitoring schedule based on your results.

Cardiac risk assessment including Cleerly coronary CTA coordination and advanced biomarker analysis is included as part of the Nivaan Health Nirvana membership annual health evaluation. Members receive physician interpretation of results, a personalized cardiovascular prevention strategy, and ongoing monitoring. Speak with a Nivaan physician about what is included in your specific membership tier.

Terms & Conditions

Photography by Amaly Vazquez

Brand & Website by Set In Simple

Privacy Policy

Why Nivaan

Common Questions

Contact

Home

Schedule A Discovery Call

Memberships

Services

Our Story

Voices from Our Extended Family

Schedule A Discovery Call

"After years of being rushed through appointments and dismissed by specialists, Nivaan Health changed everything. Drs. Goswamy and Chopra took the time to understand my full story—emotionally, physically, and medically. Their in-home visits are deeply thorough, unrushed, and surprisingly calming. This is not just medicine. It’s restoration."

“For the first time in years, I feel truly seen by my doctors.”

— M.C., Coral Gables

"As a business owner and father of three, I needed more than great care—I needed accessible care. With Nivaan Health, I receive expert medical attention in my own home, on my schedule, with an attention to detail I didn’t think existed anymore. This is what modern healthcare should be."

“Nivaan fits into my life—without compromise.”

— R.K., Pinecrest

"For years, I was told my labs were ‘normal,’ yet I felt constantly drained. At Nivaan Health, we went deeper. Through advanced diagnostics and a personalized functional medicine plan, I finally uncovered the root causes behind my fatigue. Today, I feel more energized and clear-headed than I have in a decade."

“They helped me reclaim my energy, focus, and health.”

— L.S., Coconut Grove

They coordinated a biopsy seamlessly, arranged expedited appointments with top specialists, and kept me informed with clarity and compassion throughout the entire process. Their proactive, hands-on approach turned a frightening moment into one of confidence and reassurance. Thanks to their expertise and personalized care, I felt empowered—not overwhelmed—and I truly believe they saved my life."